Email not displaying properly? View email in your browser
Vertical-Talk Healthcare   >  Oral Peptides
>  Generic Approvals
>  AI Hallucinations
  August 2026   e-Newsletter Advertise | Editorial Calendar | Mediapack  
Yokogawa
Latest e-Book
  Expert Talk
  Author Guidelines
  Upcoming Webinars
  Advertorials
  Register & Subscribe
  Event Posting
  Insights Hub
Articles
  Beyond The Needle
Navigating Mucosal Toxicity in Next-gen Oral Peptides
Dr. Sanjesh Kumar, Assistant Professor, Chandigarh University
Dr. Mansi Singh, Academician and Researcher, Babasaheb Bhimrao Ambedkar University
As drug pipelines drastically change their focus from injections to non-invasive oral peptides, first-in-human trial designs are necessary...
  Navigating Regulatory Frameworks: Generic Approvals in Latin...
Bhavya Sridevi Sundaraneedi, Master’s student of Regulatory Affairs, National Institute of Pharmaceutical Education and Research (NIPER- Raebareli).
Dr. Rahul Shukla, Assistant Professor, Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research (NIPER- Raebareli).
Latin America is a rapidly expanding pharmaceutical market, with Brazil and Mexico leading the region in generics. This article presents...
  Moving from Code to Consequence
Confronting AI hallucinations in predictive toxicology
Dr. Sanjesh Kumar, Assistant Professor, Chandigarh University
Dr. Disha Marwaha, Assistant Professor, Chandigarh University
While pharmaceutical R&D moves from post synthesis, reactive testing to in silico, proactive trial simulations, generative AI platforms can now...
News
Ultragenyx Receives U.S. FDA Approval for...
Lotus Pharmaceutical Receives PMDA...
Techno Trends
 MannKind Introduces First-and-Only Afrezza® Therapy for Treating...
 Praxis Introduces Breakthrough Elsunersen Therapy for Treating...
 Lilly Introduces Breakthrough Olomorasib Therapy for Treating...
Press Releases
Syneos Health Advances AI-Powered Clinical...
U.S. FDA Accepts Teva’s New Drug Application...
Projects
 Novartis to Invest US$23 Billion in Denton, Texas, USA
 Johnson & Johnson to Invest US$1 Billion in Jacksonville, Florida, USA
 BeOne Medicines to Invest US$300 Million in Hopewell, New Jersey, USA
Modular Mobile Facility
Events
25 - 27 Aug, 2026
CPHI Korea 2026
26 - 27 Aug, 2026
MEDevice Boston
14 - 15 Sep, 2026
16th American DDF Summit 2026
Research Insights
 DNA Oligonucleotides Block Viral Entry of SARS-CoV-2 Omicron Variants
 Tissue-specific Transfer Learning Improves Functional Variant...
 Integrating multi-type features and knowledge graph for graded...
Whitepapers
  Neural Network-Driven Lead Optimization with Embedded ADMET...
  Newsletter Subscribe  |  e-book Archives  | Advisory Board
Follow Us Facebook Twitter linkedin
www.pharmafocusasia.com - Owned by Ochre Digi Media Pvt Ltd.
Email: enquiry@pharmafocusasia.com